Novo Nordisk A/S (LON:0QIU)
305.42
-1.40 (-0.46%)
At close: Dec 18, 2025
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 158.6 billion as of December 19, 2025. Its market cap has decreased by -58.99% in one year.
Market Cap
158.60B
Enterprise Value
166.65B
Revenue
36.88B
Ranking
n/a
PE Ratio
13.08
Stock Price
305.42
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 4.46B to 158.60B, an increase of 3,455.64%. That is a compound annual growth rate of 13.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 161.52B | -47.61% |
| Dec 30, 2024 | 308.32B | -14.91% |
| Dec 29, 2023 | 362.35B | 43.42% |
| Dec 30, 2022 | 252.66B | 33.68% |
| Dec 30, 2021 | 189.00B | 57.73% |
| Dec 30, 2020 | 119.83B | 15.27% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 209.44B |
| HSBC Holdings | 192.86B |
| Shell | 154.77B |
| Unilever | 107.28B |
| Rio Tinto Group | 96.41B |
| British American Tobacco p.l.c. | 93.44B |
| Rolls-Royce Holdings | 93.25B |
| GSK plc | 73.62B |